|
|
||||||||
Published online before print November 21, 2003
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||



,1
* Departments of Hematology and Immunology, University Medical Center Utrecht, The Netherlands; and
Department of Immunology, Erasmus University Medical Center Rotterdam, The Netherlands
1 Correspondence: Department of Immunology, Erasmus University Medical Center Rotterdam, Dr. Molewaterplein 50, 3015 GE Rotterdam, The Netherlands. E-mail: f.staal{at}erasmusmc.nl
The replacement of bone marrow (BM) as a conventional source of stem cell (SC) by umbilical cord blood (UCB) and granulocyte-colony stimulating factor-mobilized peripheral blood SC (PBSC) has brought about clinical advantages. However, several studies have demonstrated that UCB CD34+ cells and PBSC significantly differ from BM CD34+ cells qualitatively and quantitatively. Here, we quantified the number of SC in purified BM, UCB CD34+ cells, and CD34+ PBSC using in vitro and in vivo assays for human hematopoietic SC (HSC) activity. A cobblestone area-forming cell (CAFC) assay showed that UCB CD34+ cells contained the highest frequency of CAFCwk6 (3.6- to tenfold higher than BM CD34+ cells and PBSC, respectively), and the engraftment capacity in vivo by nonobese diabetic/severe combined immunodeficiency repopulation assay was also significantly greater than BM CD34+, with a higher proportion of CD45+ cells detected in the recipients at a lower cell dose. To understand the molecular characteristics underlying these functional differences, we performed several DNA microarray experiments using Affymetrix gene chips, containing 12,600 genes. Comparative analysis of gene-expression profiles showed differential expression of 51 genes between BM and UCB CD34+ SC and 64 genes between BM CD34+ cells and PBSC. These genes are involved in proliferation, differentiation, apoptosis, and engraftment capacity of SC. Thus, the molecular expression profiles reported here confirmed functional differences observed among the SC sources. Moreover, this report provides new insights to describe the molecular phenotype of CD34+ HSC and leads to a better understanding of the discrepancy among the SC sources.
Key Words: peripheral blood stem cell G-CSF umbilical cord blood bone marrow microarray
This article has been cited by other articles:
![]() |
S. M. Graham, J. K. Vass, T. L. Holyoake, and G. J. Graham Transcriptional Analysis of Quiescent and Proliferating CD34+ Human Hemopoietic Cells from Normal and Chronic Myeloid Leukemia Sources Stem Cells, December 1, 2007; 25(12): 3111 - 3120. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Zhao, A. Raouf, D. Kent, J. Khattra, A. Delaney, A. Schnerch, J. Asano, H. McDonald, C. Chan, S. Jones, et al. A Modified Polymerase Chain Reaction-Long Serial Analysis of Gene Expression Protocol Identifies Novel Transcripts in Human CD34+ Bone Marrow Cells Stem Cells, July 1, 2007; 25(7): 1681 - 1689. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Martin-Rendon, S. J.M. Hale, D. Ryan, D. Baban, S. P. Forde, M. Roubelakis, D. Sweeney, M. Moukayed, A. L. Harris, K. Davies, et al. Transcriptional Profiling of Human Cord Blood CD133+ and Cultured Bone Marrow Mesenchymal Stem Cells in Response to Hypoxia Stem Cells, April 1, 2007; 25(4): 1003 - 1012. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. A. Panepucci, R. T. Calado, V. Rocha, R. Proto-Siqueira, W. A. Silva Jr., and M. A. Zago Higher Expression of Transcription Targets and Components of the Nuclear Factor-{kappa}B Pathway Is a Distinctive Feature of Umbilical Cord Blood CD34+ Precursors Stem Cells, January 1, 2007; 25(1): 189 - 196. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. Keller, S. Addya, R. Vadigepalli, B. Banini, K. Delgrosso, H. Huang, and S. Surrey Transcriptional regulatory network analysis of developing human erythroid progenitors reveals patterns of coregulation and potential transcriptional regulators Physiol Genomics, December 13, 2006; 28(1): 114 - 128. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. G. Moneypenny, J. Shao, Y. Song, and E. P. Gallagher MLL rearrangements are induced by low doses of etoposide in human fetal hematopoietic stem cells Carcinogenesis, April 1, 2006; 27(4): 874 - 881. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Jaatinen, H. Hemmoranta, S. Hautaniemi, J. Niemi, D. Nicorici, J. Laine, O. Yli-Harja, and J. Partanen Global Gene Expression Profile of Human Cord Blood-Derived CD133+ Cells Stem Cells, March 1, 2006; 24(3): 631 - 641. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Toren, B. Bielorai, J. Jacob-Hirsch, T. Fisher, D. Kreiser, O. Moran, S. Zeligson, D. Givol, A. Yitzhaky, J. Itskovitz-Eldor, et al. CD133-Positive Hematopoietic Stem Cell "Stemness" Genes Contain Many Genes Mutated or Abnormally Expressed in Leukemia Stem Cells, September 1, 2005; 23(8): 1142 - 1153. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Wagner, R. Saffrich, U. Wirkner, V. Eckstein, J. Blake, A. Ansorge, C. Schwager, F. Wein, K. Miesala, W. Ansorge, et al. Hematopoietic Progenitor Cells and Cellular Microenvironment: Behavioral and Molecular Changes upon Interaction Stem Cells, September 1, 2005; 23(8): 1180 - 1191. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Ioannidis, L. G. Mahaira, S. A. Perez, A. D. Gritzapis, P. A. Sotiropoulou, G. J. Kavalakis, A. I. Antsaklis, C. N. Baxevanis, and M. Papamichail CRD-BP/IMP1 Expression Characterizes Cord Blood CD34+ Stem Cells and Affects c-myc and IGF-II Expression in MCF-7 Cancer Cells J. Biol. Chem., May 20, 2005; 280(20): 20086 - 20093. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. C. Jones, A. Tefferi, P. T. Vuong, J. C. Desmond, W.-K. Hofmann, and H. P. Koeffler Detection of Aberrant Gene Expression in CD34+ Hematopoietic Stem Cells from Patients with Agnogenic Myeloid Metaplasia Using Oligonucleotide Microarrays Stem Cells, May 1, 2005; 23(5): 631 - 637. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Manfredini, R. Zini, S. Salati, M. Siena, E. Tenedini, E. Tagliafico, M. Montanari, T. Zanocco-Marani, C. Gemelli, T. Vignudelli, et al. The Kinetic Status of Hematopoietic Stem Cell Subpopulations Underlies a Differential Expression of Genes Involved in Self-Renewal, Commitment, and Engraftment Stem Cells, April 1, 2005; 23(4): 496 - 506. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Tse and M. J. Laughlin Umbilical Cord Blood Transplantation: A New Alternative Option Hematology, January 1, 2005; 2005(1): 377 - 383. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |